Lee J M, Bernstein A
Division of Molecular and Developmental Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Cancer Metastasis Rev. 1995 Jun;14(2):149-61. doi: 10.1007/BF00665797.
One of the most commonly detected abnormalities in human cancer is mutation of the p53 tumour suppressor gene. Intrinsic to the function of p53 is its ability to induce apoptotic cell death and to cause cell cycle arrest. Moreover, p53 plays an important role in controlling the cellular response to DNA damaging agents such as ionizing radiation and cancer chemotherapeutic drugs. Loss of p53 function causes increased resistance to radiation and chemotherapeutic agents, and there is increasing evidence that p53 mutational status is an important determinant of clinical outcome in cancer. This review will focus on recent data describing the biochemistry of p53 function, its role in mediating apoptosis and cell cycle arrest and in the control of tumour growth and death.
人类癌症中最常检测到的异常之一是p53肿瘤抑制基因的突变。p53功能的内在特性是其诱导凋亡性细胞死亡和导致细胞周期停滞的能力。此外,p53在控制细胞对DNA损伤剂(如电离辐射和癌症化疗药物)的反应中起重要作用。p53功能的丧失导致对辐射和化疗药物的抗性增加,并且越来越多的证据表明p53突变状态是癌症临床结果的重要决定因素。本综述将聚焦于描述p53功能生物化学、其在介导凋亡和细胞周期停滞以及控制肿瘤生长和死亡中的作用的最新数据。